亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Trends in Complications and Outcomes in Patients Aged 65 Years and Younger Undergoing Total Knee Arthroplasty: Data From the American Joint Replacement Registry

医学 生存曲线 共病 查尔森共病指数 关节置换术 外科 单变量分析 回顾性队列研究 人口
作者
Akash Shah,David Alexander Cieremans,James Slover,Ran Schwarzkopf,Morteza Meftah
出处
期刊:Journal of the American Academy of Orthopaedic Surgeons [Wolters Kluwer]
卷期号:6 (6)
标识
DOI:10.5435/jaaosglobal-d-22-00116
摘要

The purpose of this study was to identify common complications and the rates of readmission and revision in total knee arthroplasty (TKA) patients younger than 65 years.Using the American Joint Replacement Registry, we conducted a retrospective review of all TKAs done in patients aged 18 to 65 years from 2012 to 2020. Demographic factors such as age, sex, Charlson Comorbidity Index (CCI), and preoperative Veterans RAND 12-Item Health Survey Physical Component Summary (VR-12 PCS) scores were collected. We excluded patients older than 65 years and revision, oncologic, and nonelective cases. Primary outcomes included cumulative revision rate, 90-day readmission rate, and reason for revision. Univariate analysis and the Kaplan-Meier method were used.Six thousand one hundred seventy-nine patients were included. The average age was 58.8 years (SD 5.5 years), 61% were female, 82% were White, and 88% had a CCI of 0 (1 = 8% and ≥2 = 4%). The mean follow-up was 42.51 months. Seventy-four patients (1.2%) underwent revision. Sixty-nine patients (1.1%) were readmitted within 90 days. No factors assessed increased revision rates. Revision-free survivorship was 98.7% (95% CI 98.4 to 99.0) and 98.6% (95% CI 98.2 to 99.0) at 5 and 8 years, respectively. Infection (15%), aseptic loosening (14%), and instability (12%) were the most common indications for revision.TKA done in young and presumed active patients has excellent survivorship. Long-term follow-up is needed to assess survival trends in this growing population.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
9秒前
彭于晏应助TszPok采纳,获得10
10秒前
10秒前
CipherSage应助啦啦啦采纳,获得10
10秒前
azizo完成签到,获得积分10
12秒前
13秒前
KamilahKupps发布了新的文献求助10
15秒前
AQI完成签到,获得积分10
19秒前
22秒前
22秒前
23秒前
26秒前
bainwei发布了新的文献求助10
26秒前
fanjinze完成签到,获得积分10
26秒前
26秒前
今天发布了新的文献求助10
26秒前
小柏学长完成签到,获得积分10
27秒前
曹琳完成签到,获得积分10
27秒前
深情安青应助科研通管家采纳,获得30
30秒前
windy应助科研通管家采纳,获得20
30秒前
NIUB发布了新的文献求助10
31秒前
azizo发布了新的文献求助10
32秒前
哈喽完成签到,获得积分10
38秒前
bainwei完成签到,获得积分10
39秒前
KamilahKupps发布了新的文献求助10
44秒前
Leofar完成签到 ,获得积分10
44秒前
酷波er应助今天采纳,获得10
44秒前
50秒前
51秒前
月未见明完成签到 ,获得积分10
52秒前
今天完成签到,获得积分10
52秒前
666666666666666完成签到 ,获得积分10
53秒前
Mercury2024完成签到,获得积分10
55秒前
斯文尔阳发布了新的文献求助10
55秒前
彭于晏应助Maisie采纳,获得10
58秒前
复杂妙海完成签到,获得积分10
58秒前
1分钟前
1分钟前
1分钟前
wanci应助七七七采纳,获得10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
First commercial application of ELCRES™ HTV150A film in Nichicon capacitors for AC-DC inverters: SABIC at PCIM Europe 1000
Feldspar inclusion dating of ceramics and burnt stones 1000
Digital and Social Media Marketing 600
Zeolites: From Fundamentals to Emerging Applications 600
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5987869
求助须知:如何正确求助?哪些是违规求助? 7408241
关于积分的说明 16048438
捐赠科研通 5128481
什么是DOI,文献DOI怎么找? 2751750
邀请新用户注册赠送积分活动 1723056
关于科研通互助平台的介绍 1627061